FDA NDC Directory · JSON-LD · Markdown

Priftin

NDC 0088-2102 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Generic namerifapentine
Labeler / Manufacturersanofi-aventis U.S. LLC
Marketing categoryNew Drug Application (innovator) · App NDA021024
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsRIFAPENTINE (150 mg/1)
Marketing started20170208
Package count1

External sources

Source: openFDA. Public-domain (CC0).